Literature DB >> 28346226

A TLR9-dependent checkpoint governs B cell responses to DNA-containing antigens.

Vishal J Sindhava, Michael A Oropallo, Krishna Moody, Martin Naradikian, Lauren E Higdon, Lin Zhou, Arpita Myles, Nathaniel Green, Kerstin Nündel, William Stohl, Amanda M Schmidt, Wei Cao, Stephanie Dorta-Estremera, Taku Kambayashi, Ann Marshak-Rothstein, Michael P Cancro.   

Abstract

Mature B cell pools retain a substantial proportion of polyreactive and self-reactive clonotypes, suggesting that activation checkpoints exist to reduce the initiation of autoreactive B cell responses. Here, we have described a relationship among the B cell receptor (BCR), TLR9, and cytokine signals that regulate B cell responses to DNA-containing antigens. In both mouse and human B cells, BCR ligands that deliver a TLR9 agonist induce an initial proliferative burst that is followed by apoptotic death. The latter mechanism involves p38-dependent G1 cell-cycle arrest and subsequent intrinsic mitochondrial apoptosis and is shared by all preimmune murine B cell subsets and CD27- human B cells. Survival or costimulatory signals rescue B cells from this fate, but the outcome varies depending on the signals involved. B lymphocyte stimulator (BLyS) engenders survival and antibody secretion, whereas CD40 costimulation with IL-21 or IFN-γ promotes a T-bet+ B cell phenotype. Finally, in vivo immunization studies revealed that when protein antigens are conjugated with DNA, the humoral immune response is blunted and acquires features associated with T-bet+ B cell differentiation. We propose that this mechanism integrating BCR, TLR9, and cytokine signals provides a peripheral checkpoint for DNA-containing antigens that, if circumvented by survival and differentiative cues, yields B cells with the autoimmune-associated T-bet+ phenotype.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28346226      PMCID: PMC5409796          DOI: 10.1172/JCI89931

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  82 in total

Review 1.  BAFF, APRIL and their receptors: structure, function and signaling.

Authors:  Claudia Bossen; Pascal Schneider
Journal:  Semin Immunol       Date:  2006-08-17       Impact factor: 11.130

2.  Chronic spinal cord injury impairs primary antibody responses but spares existing humoral immunity in mice.

Authors:  Michael A Oropallo; Katherine S Held; Radhika Goenka; Sifat A Ahmad; Patrick J O'Neill; Oswald Steward; Thomas E Lane; Michael P Cancro
Journal:  J Immunol       Date:  2012-04-20       Impact factor: 5.422

3.  FcγRIIB regulation of BCR/TLR-dependent autoreactive B-cell responses.

Authors:  Ana M Avalos; Melissa B Uccellini; Petar Lenert; Gregory A Viglianti; Ann Marshak-Rothstein
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

4.  TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus.

Authors:  Kevin M Nickerson; Sean R Christensen; Jonathan Shupe; Michael Kashgarian; Daniel Kim; Keith Elkon; Mark J Shlomchik
Journal:  J Immunol       Date:  2010-01-20       Impact factor: 5.422

5.  Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice.

Authors:  Marie-Laure Santiago-Raber; Isabelle Dunand-Sauthier; Tianfu Wu; Quan-Zhen Li; Satoshi Uematsu; Shizuo Akira; Walter Reith; Chandra Mohan; Brian L Kotzin; Shozo Izui
Journal:  J Autoimmun       Date:  2009-11-26       Impact factor: 7.094

Review 6.  The role of IL-21 in regulating B-cell function in health and disease.

Authors:  Rachel Ettinger; Stefan Kuchen; Peter E Lipsky
Journal:  Immunol Rev       Date:  2008-06       Impact factor: 12.988

7.  Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation.

Authors:  M Shlomchik; M Mascelli; H Shan; M Z Radic; D Pisetsky; A Marshak-Rothstein; M Weigert
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

8.  bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice.

Authors:  D A Grillot; R Merino; J C Pena; W C Fanslow; F D Finkelman; C B Thompson; G Nunez
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

9.  B lymphocytes may escape tolerance by revising their antigen receptors.

Authors:  M Z Radic; J Erikson; S Litwin; M Weigert
Journal:  J Exp Med       Date:  1993-04-01       Impact factor: 14.307

10.  Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation.

Authors:  Radhika Goenka; Andrew H Matthews; Bochao Zhang; Patrick J O'Neill; Jean L Scholz; Thi-Sau Migone; Warren J Leonard; William Stohl; Uri Hershberg; Michael P Cancro
Journal:  J Exp Med       Date:  2013-12-23       Impact factor: 14.307

View more
  33 in total

1.  Fas ligand promotes an inducible TLR-dependent model of cutaneous lupus-like inflammation.

Authors:  Purvi Mande; Bahar Zirak; Wei-Che Ko; Keyon Taravati; Karen L Bride; Tia Y Brodeur; April Deng; Karen Dresser; Zhaozhao Jiang; Rachel Ettinger; Katherine A Fitzgerald; Michael D Rosenblum; John E Harris; Ann Marshak-Rothstein
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

Review 2.  A pathogenic role of plasmacytoid dendritic cells in autoimmunity and chronic viral infection.

Authors:  Franck J Barrat; Lishan Su
Journal:  J Exp Med       Date:  2019-08-16       Impact factor: 14.307

Review 3.  BAFF inhibition in SLE-Is tolerance restored?

Authors:  Shaun W Jackson; Anne Davidson
Journal:  Immunol Rev       Date:  2019-09-28       Impact factor: 12.988

4.  Cross-Reactive Antigen Expressed by B6 Splenocytes Drives Receptor Editing and Marginal Zone Differentiation of IgG2a-Reactive AM14 Vκ8 B Cells.

Authors:  Kerstin Nündel; Purvi Mande; Stephanie L Moses; Patricia Busto; Jaime L Cullen; Madelyn R Schmidt; Mark J Shlomchik; Robert T Woodland; Ann Marshak-Rothstein
Journal:  J Immunol       Date:  2019-09-18       Impact factor: 5.422

5.  DNA Sensing in the Innate Immune Response.

Authors:  Benoit Briard; David E Place; Thirumala-Devi Kanneganti
Journal:  Physiology (Bethesda)       Date:  2020-03-01

6.  Impaired TLR9 responses in B cells from patients with systemic lupus erythematosus.

Authors:  Vincent Gies; Jean-Nicolas Schickel; Sophie Jung; Aurélie Joublin; Salomé Glauzy; Anne-Marie Knapp; Anne Soley; Vincent Poindron; Aurélien Guffroy; Jin-Young Choi; Jacques-Eric Gottenberg; Jennifer H Anolik; Thierry Martin; Pauline Soulas-Sprauel; Eric Meffre; Anne-Sophie Korganow
Journal:  JCI Insight       Date:  2018-03-08

7.  Signals that drive T-bet expression in B cells.

Authors:  Arpita Myles; Patricia J Gearhart; Michael P Cancro
Journal:  Cell Immunol       Date:  2017-09-11       Impact factor: 4.868

8.  Transitional B cells in quiescent SLE: An early checkpoint imprinted by IFN.

Authors:  Yannick Dieudonné; Vincent Gies; Aurélien Guffroy; Céline Keime; Anna K Bird; Jane Liesveld; Jennifer L Barnas; Vincent Poindron; Nawal Douiri; Pauline Soulas-Sprauel; Thierry Martin; Eric Meffre; Jennifer H Anolik; Anne-Sophie Korganow
Journal:  J Autoimmun       Date:  2019-05-10       Impact factor: 7.094

9.  IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation.

Authors:  Esther Zumaquero; Sara L Stone; Christopher D Scharer; Scott A Jenks; Anoma Nellore; Betty Mousseau; Antonio Rosal-Vela; Davide Botta; John E Bradley; Wojciech Wojciechowski; Travis Ptacek; Maria I Danila; Jeffrey C Edberg; S Louis Bridges; Robert P Kimberly; W Winn Chatham; Trenton R Schoeb; Alexander F Rosenberg; Jeremy M Boss; Ignacio Sanz; Frances E Lund
Journal:  Elife       Date:  2019-05-15       Impact factor: 8.140

10.  B cell-intrinsic TLR9 expression is protective in murine lupus.

Authors:  Jeremy S Tilstra; Shinu John; Rachael A Gordon; Claire Leibler; Michael Kashgarian; Sheldon Bastacky; Kevin M Nickerson; Mark J Shlomchik
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.